The cost of Rocklatan eye drops can vary based on insurance coverage and pharmacy. For instance, a 30-day supply might cost around $480 without insurance. However, with a savings card from the manufacturer, the out-of-pocket cost could be reduced to as low as $10 per month for eligible patients [1].
How much do Rocklatan eye drops cost without insurance?
Without insurance, the retail price for Rocklatan (netarsudil ophthalmic solution) 0.02% is typically in the range of $450 to $500 for a 2.5 mL bottle, which is a 30-day supply. This price reflects the manufacturer's list price and does not include any potential pharmacy markups [1].
Can I get Rocklatan eye drops for free or at a lower cost?
Rocklatan offers a savings program that can significantly reduce the cost for commercially insured patients. The Rocklatan Savings Card program allows eligible individuals to pay as little as $10 for their prescription. This program has monthly and annual limits on savings [1]. Patients who are uninsured or underinsured might qualify for the company's Patient Assistance Program, which can provide free medication based on income and other eligibility criteria [1].
What is the price of Rocklatan after insurance?
The cost of Rocklatan after insurance depends heavily on the specific insurance plan. Many insurance plans cover Rocklatan, but patients may still have a co-pay. The Rocklatan Savings Card can be used to lower this co-pay for those with commercial insurance, potentially bringing the cost down to $10 per month [1]. For individuals with Medicare or Medicaid, coverage and co-pay amounts can differ, and they may not be eligible for the savings card but could potentially qualify for patient assistance programs [1].
Where can I buy Rocklatan eye drops and compare prices?
Rocklatan eye drops can be obtained through most major retail pharmacies, including those within large chain stores and independent pharmacies. To compare prices, individuals can check with their local pharmacies or use online pharmacy price comparison tools. Information about the drug and its availability can also be found on the manufacturer's website, which often includes details about savings and assistance programs [1]. DrugPatentWatch.com provides information on drug patents and exclusivity, which can indirectly influence pricing and the availability of generic alternatives [2].
When did Rocklatan become available on the market?
Rocklatan (netarsudil ophthalmic solution) was approved by the U.S. Food and Drug Administration in December 2017. It is indicated for lowering elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension [1].